Free Trial

SG Americas Securities LLC Acquires Shares of 154,907 Clarivate PLC (NYSE:CLVT)

Clarivate logo with Computer and Technology background

SG Americas Securities LLC acquired a new position in shares of Clarivate PLC (NYSE:CLVT - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 154,907 shares of the company's stock, valued at approximately $609,000.

Other large investors have also modified their holdings of the company. Clarkston Capital Partners LLC grew its stake in shares of Clarivate by 8.1% during the 4th quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company's stock valued at $359,328,000 after buying an additional 5,319,535 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Clarivate by 53.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock valued at $141,107,000 after buying an additional 9,691,104 shares during the period. Thompson Siegel & Walmsley LLC grew its stake in shares of Clarivate by 14.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock valued at $53,333,000 after buying an additional 1,323,329 shares during the period. Vanguard Group Inc. grew its stake in shares of Clarivate by 6.6% during the 4th quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company's stock valued at $44,454,000 after buying an additional 538,907 shares during the period. Finally, Invenomic Capital Management LP grew its stake in shares of Clarivate by 11.3% during the 4th quarter. Invenomic Capital Management LP now owns 6,585,707 shares of the company's stock valued at $33,455,000 after buying an additional 667,146 shares during the period. 85.72% of the stock is currently owned by hedge funds and other institutional investors.

Clarivate Stock Down 1.1%

Clarivate stock traded down $0.05 during trading on Friday, reaching $4.20. 7,726,216 shares of the company's stock were exchanged, compared to its average volume of 5,195,923. The company's 50-day moving average is $4.09 and its two-hundred day moving average is $4.48. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.88. Clarivate PLC has a 52-week low of $3.04 and a 52-week high of $7.15. The firm has a market cap of $2.87 billion, a price-to-earnings ratio of -4.32 and a beta of 1.47.

Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.14 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. Clarivate had a negative net margin of 26.32% and a positive return on equity of 8.75%. The firm had revenue of $593.70 million during the quarter, compared to analysts' expectations of $574.03 million. During the same period in the prior year, the company earned $0.14 EPS. The firm's revenue was down 4.4% on a year-over-year basis. On average, analysts predict that Clarivate PLC will post 0.63 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday.

Read Our Latest Stock Report on Clarivate

Clarivate Profile

(Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

Featured Stories

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Should You Invest $1,000 in Clarivate Right Now?

Before you consider Clarivate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.

While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines